ORCID Profile
0000-0003-1054-4362
Current Organisation
Harbin Institute of Technology (Shenzhen)
Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the Feedback Form.
Publisher: Elsevier BV
Date: 10-2021
Publisher: American Chemical Society (ACS)
Date: 24-08-2022
Abstract: Paper microfluidics has been extensively exploited as a powerful tool for environmental and medical detection applications. Both flow delay and compatibility with either polar or non-polar reagents are indispensable for the automation of detections requiring multiple reaction steps. This article reports the systematic studies of a 3D-printing protocol, characterization, and application of both the partially and fully penetrated polydimethylsiloxane (PDMS) barriers for flexible flow control in paper microfluidics. The physical parameters of PDMS barriers printed using a simple liquid dispenser were found related to the printing pressure, speed, diffusion time after printing, baking temperature, and PDMS viscosity. The capability of PDMS barriers to confine the flow of non-polar solvents was demonstrated using oil flow in both wax- and PDMS-surrounded channels. It was identified that the minimum width of channels to prevent leakage was 470 ± 54 μm, which was as narrow as that fabricated using st s from lithography. Both the partially penetrated barriers (PPBs) and constriction channels were of the capability to delay flow in paper microfluidics. Additionally, an
Publisher: Wiley
Date: 31-05-2021
DOI: 10.1002/IJC.33685
Abstract: Tobacco smoke is a known carcinogen, but the magnitude of smoking‐related cancer risk depends on country‐specific, generational smoking patterns. We quantified cancer risk in relation to smoking in a population‐based cohort, the 45 and Up Study (2006‐2009) in New South Wales, Australia. Cox proportional hazards regressions estimated adjusted hazard ratios (HR) by self‐reported smoking history at baseline (2006‐2009) for incident, primary cancers via linkage to cancer registry data to 2013 and cancer death data to 2015. Among 229 028 participants aged ≥45 years, 18 475 cancers and 5382 cancer deaths occurred. Current‐smokers had increased risks of all cancers combined (HR = 1.42, 95% confidence interval [CI], 1.34‐1.51), cancers of the lung (HR = 17.66, 95%CI, 14.65‐21.29), larynx (HR = 11.29, 95%CI, 5.49‐23.20), head‐and‐neck (HR = 2.53, 95%CI, 1.87‐3.41), oesophagus (HR = 3.84, 95%CI, 2.33‐6.35), liver (HR = 4.07, 95%CI, 2.55‐6.51), bladder (HR = 3.08, 95%CI, 2.00‐4.73), pancreas (HR = 2.68, 95%CI, 1.93‐3.71), colorectum (HR = 1.31, 95%CI, 1.09‐1.57) and unknown primary site (HR = 3.26, 95%CI, 2.19‐4.84) versus never‐smokers. Hazards increased with increasing smoking intensity compared to never‐smokers, lung cancer HR = 9.22 (95%CI, 5.14‐16.55) for 1‐5 cigarettes/day and 38.61 (95%CI, 25.65‐58.13) for cigarettes/day. Lung cancer risk was lower with quitting at any age but remained higher than never‐smokers for quitters aged y. By age 80y, an estimated 48.3% of current‐smokers (41.1% never‐smokers) will develop cancer, and 14% will develop lung cancer, including 7.7% currently smoking 1‐5 cigarettes/day and 26.4% for cigarettes/day (1.0% never‐smokers). Cancer risk for Australian smokers is significant, even for 'light' smokers. These contemporary estimates underpin the need for continued investment in strategies to prevent smoking uptake and facilitate cessation, which remain key to reducing cancer morbidity and mortality worldwide.
Publisher: arXiv
Date: 2022
Publisher: Royal Society of Chemistry (RSC)
Date: 2020
DOI: 10.1039/C9NR09309E
Abstract: Efficient interfacial light–electric interconversion in van der Waals heterostructures is critical for their optoelectronic applications.
Publisher: Royal Society of Chemistry (RSC)
Date: 2023
DOI: 10.1039/D3LC00310H
Abstract: A novel microfluidic technology integrating capturing, elasticity measurement, and printing of single cells based on the precise regulation of pressure across an array of U-shaped microtraps.
Publisher: Royal Society of Chemistry (RSC)
Date: 2022
DOI: 10.1039/D2RE00103A
Abstract: A low-cost 3D micromixer was developed using a desktop-class 3D printer and it demonstrated unprecedented mixing performance over the widest range of flow conditions.
Publisher: American Chemical Society (ACS)
Date: 23-05-2022
DOI: 10.1021/ACS.ANALCHEM.2C00865
Abstract: Nanobodies, also known as VHHs, originate from the serum of Camelidae. Nanobodies have considerable advantages over conventional antibodies, including smaller size, more modifiable, and deeper tissue penetration, making them promising tools for immunotherapy and antibody-drug development. A high-throughput nanobody screening platform is critical to the rapid development of nanobodies. To date, droplet-based microfluidic systems have exhibited improved performance compared to the traditional phage display technology in terms of time and throughput. In realistic situations, however, it is difficult to directly apply the technology to the screening of nanobodies. Requirements of plasma cell enrichment and high cell viability, as well as a lack of related commercial reagents, are leading causes for impeding the development of novel methods. We overcame these obstacles by constructing a eukaryotic display system that secretes nanobodies utilizing homologous recombination and eukaryotic transformation technologies, and the significant advantages are that it is independent of primary cell viability and it does not require plasma cell enrichment in advance. Next, a signal capture system of "SA-beads + Biotin-antigen + nanobody-6 × His + fluorescence-labeled anti-6 × His (secondary antibody)" was designed for precise localization of the eukaryotic-expressed nanobodies in a droplet. Based on this innovation, we screened 293T cells expressing anti-PD-L1 nanobodies with a high positive rate of targeted cells (up to 99.8%). Then, single-cell transcriptomic profiling uncovered the intercellular heterogeneity and BCR sequence of target cells at a single-cell level. The complete complementarity determining region (CDR3) structure was obtained, which was totally consistent with the BCR reference. This study expanded the linkage between microfluidic technology and nanobody applications and also showed potential to accelerate the rapid transformation of nanobodies in the large-scale market.
Publisher: Royal Society of Chemistry (RSC)
Date: 2017
DOI: 10.1039/C7NR01511A
Abstract: Surface-Enhanced Raman Scattering (SERS) is emerging as a promising strategy for the quantification of immunoglobulin G (IgG) due to its inherent high sensitivity and specificity however, it remains challenging to integrate SERS detection with a microfluidic system in a simple, efficient and low-cost manner. Here, we report on a novel bifunctional plasmonic-magnetic particle-based immunoassay, in which plasmonic nanoparticles act as soluble SERS immunosubstrates, whereas magnetic particles are for promoting micromixing in a microfluidic chip. With this novel SERS immunosubstrate in conjunction with the unique microfluidic system, we could substantially reduce the assay time from 4 hours to 80 minutes as well as enhance the detection specificity by about 70% in comparison to a non-microfluidic immunoassay. Compared to previous microfluidic SERS systems, our strategy offers a simple microfluidic chip design with only one well for mixing, washing and detection.
Publisher: Royal Society of Chemistry (RSC)
Date: 2018
DOI: 10.1039/C8NR06367B
Abstract: The integration of acoustic micromixing and single bead trapping enables the identification of fluorescent signals from multiple biomarkers within minutes.
Publisher: American Chemical Society (ACS)
Date: 15-08-2023
Publisher: Springer Science and Business Media LLC
Date: 11-10-2020
DOI: 10.1038/S41416-020-01101-2
Abstract: Although overall alcohol consumption is known to increase the risk of a number of cancers internationally, evidence for Australia and evidence regarding the pattern of drinking and cancer risk is limited. Adjusted hazard ratios (HR) and 95% confidence intervals (CI) for cancer risk in relation to overall alcohol consumption (drinks/week) and pattern of drinking were calculated using Cox proportional hazard regressions for 226,162 participants aged ≥45 years (2006–2009) in the 45 and Up Study, an Australian prospective cohort study. Incident primary cancer cases were ascertained by linkage to the New South Wales Cancer Registry to 2013 by the Centre for Health Record Linkage. Over a median of 5.4 years, 17,332 cancers were diagnosed. Increasing levels of alcohol intake were associated with increased risk of cancers of the upper aerodigestive tract (1.19 1.10–1.29), mouth and pharynx (1.18 1.08–1.29), oesophagus (1.22 1.04–1.43), colorectum (1.09 1.04–1.15), colon (1.13 1.06–1.20), liver (1.22 1.04–1.44) and breast (1.11 1.02–1.21). Breast cancer risk was marginally associated with drinking pattern, with higher risk when intake was concentrated on 1–3 days/week compared to the same amount spread over 4–7 days ( P interaction = 0.049). Alcohol consumption confers a significant risk of cancer, and drinking pattern may be independently related to breast cancer risk.
Publisher: Royal Society of Chemistry (RSC)
Date: 2020
DOI: 10.1039/D0LC00040J
Abstract: Inoculation of single cells into separate chambers is one of the key requirements in single-cell analysis. Here we report a three-layer microfluidic platform integrated with dual-pneumatic valves for dynamic screening and printing of single cells.
Publisher: American Chemical Society (ACS)
Date: 11-01-2022
Abstract: As a typical, classical, but powerful biochemical sensing technology in analytical chemistry, enzyme-linked immunosorbent assay (ELISA) shows excellence and wide practicability for quantifying analytes of ultralow concentration. However, long incubation time and burdensome laborious multistep washing processes make it inefficient and labor-intensive for conventional ELISA. Here, we propose rod-like magnetically driven nanorobots (MNRs) for use as maneuverable immunoassay probes that facilitate a strategy for an automated and highly efficient ELISA analysis, termed nanorobots enabled ELISA (nR-ELISA). To prepare the MNRs, the self-assembled chains of Fe 3 O 4 magnetic particles are chemically coated with a thin layer of rigid silica oxide (SiO 2 ), onto which capture antibody (Ab1) is grafted to further achieve magnetically maneuverable immunoassay probes (MNR-Ab1s). We investigate the fluid velocity distribution around the MNRs at microscale using numerical simulation and empirically identify the mixing efficiency of the actively rotating MNRs. To automate the analysis process, we design and fabricate by 3-D printing a detection unit consisting of three function wells. The MNR-Ab1s can be steered into different function wells for required reaction or wishing process. The actively rotating MNR-Ab1s can enhance the binding efficacy with target analytes at microscale and greatly decrease incubation time. The integrated nR-ELISA system can significantly reduce the assay time, more importantly during which process manpower input is greatly minimized. Our simulation of the magnetic field distribution generated by Helmholtz coils demonstrates that our approach can be scaled up, which proves the feasibility of using current strategy to construct high throughput nR-ELISA detection instrument. This work of taking magnetic micro/nanobots as active immunoassay probes for automatic and efficient ELISA not only holds great potential for point-of-care testing (POCT) in future but also extends the practical applications of self-propelled micro/nanorobots into the field of analytical chemistry.
Publisher: Wiley
Date: 07-03-2019
DOI: 10.1111/ACER.13981
Abstract: Evidence suggests that people who develop serious health conditions are likely to cease drinking alcohol (sometimes known as "sick-quitters"). We quantified the likelihood of quitting drinking in relation to the onset of a variety of health conditions. Odds ratios (ORs) and 95% confidence intervals (CIs) of ceasing alcohol consumption after diagnosis of 28 health conditions and 4 general indicators of health were derived from logistic regression among 97,852 drinkers aged ≥ 45 years between baseline (2006 to 2009) and median 5.3 years of follow-up in the New South Wales 45 and Up Study. Incident health conditions at follow-up were self-reported. At follow-up, 9.6% (n = 9,438) of drinkers had ceased drinking. Drinking cessation was significantly associated with 24 of 32 health conditions examined: 15.4% of participants with newly diagnosed diabetes quit drinking (OR for quitting vs. continuing 1.77, 95% CI: 1.60 to 1.96), 16.4% with Parkinson's disease (1.71, 1.35 to 2.17), 17.8% with poor memory (1.68, 1.43 to 1.97), 19.2% with hip fracture (1.64, 1.30 to 2.06), 14.7% with stroke (1.45, 1.27 to 1.66), 12.5% with depression (1.40, 1.26 to 1.55), 15.0% with breast cancer (1.38, 1.18 to 1.61), 12.3% with heart disease (1.34, 1.25 to 1.44), and 13.3% with osteoarthritis (1.22, 1.12 to 1.33). Strong associations with quitting were observed in those with a decline in self-rated overall health (2.93, 2.53 to 3.40) and quality of life (2.68, 2.24 to 3.21). Some health conditions not significantly associated with quitting were prostate cancer, melanoma, nonmelanoma skin cancer, hay fever, and hearing loss. Findings were generally consistent for men and women, by age group and by smoking status. Diagnosis with a variety of health conditions appears to prompt drinking cessation in older adults.
Publisher: Royal Society of Chemistry (RSC)
Date: 2020
DOI: 10.1039/D0RA07694E
Abstract: PDMS-based micropillar array electrodes with increased surface area and surface modification were developed to detect biomarkers with high sensitivity.
Publisher: American Chemical Society (ACS)
Date: 14-03-2019
DOI: 10.1021/ACS.ANALCHEM.8B05764
Abstract: Microfluidic paper-based analytical devices (μPADs) have been extensively studied for disease diagnostics, food quality control, and environmental monitoring due to the advantages of low cost, portability, and simplicity. The lack of flow controllability has triggered the development of valves for such devices. This paper reports the μPADs integrating novel wax valves for distance-based detection. The valves are printed on paper and can be manually opened by organic solvents within seconds. The opened valve does not influence the flow. The μPADs with wax valves were then applied in the distance-based detection of potassium iodate and glucose. The valves allow mixing of reagents and subsequent incubation in the loading zone, resulting in a shorter detection time and larger linear detection range. This study has demonstrated a linear detection range of 0.05-0.5 mM for potassium iodate, while linear ranges of 1-5 and 2.5-80 mg/dL are achieved for glucose when total detection time is 15 and 25 min, respectively. The lower detection limit is only 1/11 of that in a previous study. The detection ranges of iodate and glucose assays cover the concentrations of iodate in salt/milk and glucose in human saliva, respectively. Due to the simplicity, reliability, and ability for high-density integration, the μPADs with wax valves are of great potential in point-of-care (s ling) applications.
Publisher: Royal Society of Chemistry (RSC)
Date: 2021
DOI: 10.1039/D1LC00638J
Abstract: This paper reports the numerical, mathematical, and experimental studies of flow delay through wax valves surrounded by PDMS walls on paper microfluidics.
Publisher: Royal Society of Chemistry (RSC)
Date: 2020
DOI: 10.1039/D0LC00092B
Abstract: The study of cell elasticity provides new insights into not only cell biology but also disease diagnosis based on cell mechanical state variation.
Publisher: Elsevier BV
Date: 12-2015
DOI: 10.1016/J.YPMED.2015.09.004
Abstract: The way in which lifestyle risk factors for chronic disease co-occur among people with different cultural backgrounds is largely unknown. This study investigated chronic disease risk among immigrants aged ≥45 years in Australia by combining common lifestyle risk factors into a weighted chronic disease risk index (CDRI). Among 64,194 immigrants and 199,908 Australian-born participants in the 45 and Up Study (2006-2009), Poisson regression was used to derive relative risks (RR) and 95% confidence intervals (CI) for five risk factors (smoking, alcohol use, overweight/obesity, physical activity, diet) by place of birth adjusting for socio-demographic characteristics. Multiple linear regression was used to determine adjusted mean differences (AMDs) in CDRI score by place of birth and years lived in Australia. Immigrants had higher RRs of smoking than Australian-born participants, lower RRs of excessive alcohol consumption and overweight/obesity, and no difference in RR for physical inactivity and insufficient fruit/vegetable intake. Participants born in the Middle East/North Africa (AMD 3.5, 95% CI 2.7, 4.3), Eastern/Central Europe (1.3, 0.8, 1.9), and Western Europe (0.5, 0.1, 0.8) had higher mean CDRI scores than Australian-born participants, while participants born in East Asia (-7.2, -7.8, -6.6), Southeast Asia (-6.6, -7.2, -6.1), Central/South Asia (-3.1, -4.0, -2.1), Sub-Saharan Africa (-1.9, -2.6, -1.2) and the United Kingdom/Ireland (-0.2, -0.5, 0.0) had lower scores. CDRI score among immigrants generally approximated that of Australian-born participants with greater years lived in Australia. This study reveals differences in potential risk of chronic disease among different immigrant groups in Australia.
Location: Australia
No related grants have been discovered for Huaying Chen.